Why Mandelic Is the Strongest Acid We Use

The position was never 'no acids'

It is a reasonable thing to assume. A barrier-first range that talks at length about lipid matrices and lamellar reorganisation, that chooses bakuchiol over retinoic acid, that warns against peels normalised into routine — such a range sounds like it would refuse acids outright.

It never has. The TERRA GLOW Rose Tonic Mist is built on two naturally derived alpha hydroxy acids — lactic acid and citric acid — alongside the Damask rose hydrosol they sit in. It has always been recommended for daily use, including on sensitive skin, because it is buffered to the skin's own slightly acidic mantle rather than pushed low for potency. Our guidance on uneven tone has always pointed toward kojic acid and plant polyphenols. What the barrier-first argument rejects, in every place it appears, is something more specific: high-percentage acids, aggressive peels, and resurfacing normalised into routine practice.

The distinction matters because 'no acids' is the kind of absolute that sounds like a principle and functions like a slogan. It cannot survive contact with the actual biology, and a brand that states it has to either break it quietly or refuse a tool the skin genuinely benefits from. Neither is honest. So here is the position, stated properly.

Two tiers, not one line

Acids are not a single category with a single answer. Aphora uses them at two distinct strengths, for two distinct jobs, and the difference is worth understanding before any of the rest makes sense.

Daily-grade is lactic and citric acid, as they appear in the Rose Tonic Mist. Lactic is the gentlest of the traditional alpha hydroxy acids and the only one with a genuine second function: it is also a component of the skin's own Natural Moisturising Factor, the mixture of water-binding compounds produced when filaggrin breaks down. So it hydrates the stratum corneum even as it renews it — which is exactly what suits a product used every morning and evening. Citric does double duty of a different kind, providing mild surface refinement while acting as the buffer that holds the formula at the acid mantle's own range rather than below it.

Treatment-grade is mandelic. Larger molecule again, lipophilic where the others are not, antibacterial where the others are not. It reaches into sebum rather than sitting in the water phase above it, and it acts on pigment. That is a different job, and it earns a different frequency: two or three evenings a week rather than twice a day.

Mandelic is also the ceiling. Not because stronger acids do not work — glycolic works, and so do peels — but because past that point the barrier pays more than it gains, and on skin that is already producing fewer lipids than it used to, that trade is a bad one. The range stops there deliberately.

What the category actually got wrong

Acids are not the problem. The habits built around them are.

Four decisions, repeated across the category for years, turned a useful tool into something the barrier has to survive. Each one had a reasonable-sounding case behind it. Each one traded how the skin functions over time for a quick sign that something was happening.

Why mandelic survives the filter

Mandelic acid is derived from bitter almond, and nearly everything useful about it follows from one physical fact: it is a large molecule. At roughly 152 daltons it is around twice the size of glycolic acid and well above lactic, and size governs how quickly and how deeply an acid moves into the stratum corneum.

Slow, shallow penetration is not a marketing softening. It is physics, and it is measurable. The acid does its work nearer the surface, where desquamation actually happens — the continual, invisible shedding of the skin's outermost dead cells — rather than driving deeper and provoking the inflammatory response that a compromised barrier cannot readily absorb.

Three further properties compound the advantage. Mandelic is lipophilic — unusual among the alpha hydroxy acids, and the reason it partitions into sebum and reaches where breakouts form rather than sitting in the water phase above them. It is antibacterial, with documented activity against the organisms involved in blemishes, so it acts on the cause rather than only on the aftermath. And it carries the lowest documented risk of post-inflammatory hyperpigmentation of the AHAs, which is why it is the acid most often reached for on rosacea-prone skin and on deeper skin tones, where a poorly chosen acid can leave marks worse than the ones it was meant to clear.

Every one of those properties points the same direction: an acid that does less, more precisely, closer to the surface.

The number on the label is not the dose

An 8% acid at pH 3.2 and an 8% acid at pH 4.0 are not the same product, and the difference is not small. What determines what the skin experiences is the free-acid fraction — how much of the acid remains un-neutralised and therefore active.

That fraction is governed by the relationship between the formula's pH and the acid's own dissociation constant. Push the pH down and the free-acid fraction climbs steeply; hold it higher and most of the acid sits in its neutralised salt form, present but quiet. Two serums can carry an identical percentage on the front of the bottle and deliver experiences several times apart in intensity.

This is why a percentage alone is close to meaningless as a comparison tool, and why 'stronger' is not a synonym for 'more effective'. A formula held at pH 3.8 to 4.0 sits close enough to the skin's own surface chemistry to do renewal work without stripping the acid mantle that the barrier's lipid-building enzymes depend on. It also complies with the accepted guidance for consumer alpha hydroxy acid products — 10% or less, at pH 3.5 or above — rather than treating that guidance as a ceiling to be approached.

Why this matters more, not less, in menopausal skin

Two words are worth having before the rest of this makes sense, because they name the thing every acid is actually acting on.

Skin renews itself from underneath. New cells form at the base of the epidermis, rise upward over several weeks, flatten, fill with keratin, and end their working life as corneocytes — the flat, dead, overlapping cells that form the outermost layer of the barrier. Think roof tiles, held together by the lipid mortar between them. Shedding those cells, a few at a time and entirely invisibly, is called desquamation. On a healthy barrier it runs continuously and you never notice it happening. Every exfoliating acid ever made is an attempt to influence that one process.

There is a genuine tension here, and it is worth naming rather than smoothing over.

After menopause, desquamation slows. Corneocytes linger at the surface longer than they used to, and that accumulation is a real part of why skin looks dull, feels rough, and stops catching light the way it once did. Renewal support is not vanity in this chapter — it addresses something that has measurably changed.

At the same time, the barrier is thinner and lipid-poor. Sebum production has dropped. The margin for error on any exfoliating step is narrower than it has ever been. So the skin that would benefit most from renewal is also the skin least able to tolerate the way renewal is conventionally delivered.

Both things are true simultaneously, and most of the category resolves the tension by picking one. Either it sells aggressive resurfacing to skin that cannot absorb it, or it refuses acids entirely and leaves the slowed turnover unaddressed. The doctrine below is the attempt to hold both — to support renewal at a dose, pH and frequency the barrier can actually carry, and to rebuild immediately afterwards.

The four rules

This is the whole position, and it applies to any acid Aphora ever uses.

What renewal should feel like

The category trained a generation to read discomfort as evidence. Tingle, sting, visible flaking — these were marketed as proof that a product was working, and gentler formulations were rejected on the grounds that they could not possibly be doing anything.

Renewal done correctly feels like almost nothing. A slight smoothness the next morning. Over several weeks, skin that catches light differently, tone that evens, texture that settles. No sting at application, no flaking, no compromise in tolerance to the products used alongside it.

If an acid stings, the answer is not that it is working. The answer is that the dose, the pH, the frequency, or the aftercare is wrong — and on a barrier that is already thinner than it was, one of those four is worth correcting before the next application, not after a course of them.